DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
Current Location:
> This Story

Forward Printable StoryPrint Comment



Business Affairs Homepage

Hospital leaders say better technology needed to capture surgical revenue opportunities

Baxter completes acquisition of RECOTHROM and PREVELEAK

Parachute Health raises $5.5 million seed round to transform how patients receive critical medical equipment

Orthofix announces agreement to acquire Spinal Kinetics

Terso Solutions expands manufacturing capabilities with new U.S. production facility

Aetna shareholders approve proposed acquisition by CVS Health

Foundation Medicine and Guardant Health agree to resolve false advertising lawsuit

Cano Health acquires Tampa-based Rangel Medical Center

Mount Sinai and Hudson Yards announce partnership

Stratasys and Eckhart sign agreement with exclusive rights to accelerate 3-D printing adoption for factory tools

GE Healthcare acquires Asymptote

Press releases may be edited for formatting or style
Chalfont St Giles, UK – 11 April 2017 – GE Healthcare has acquired Asymptote Limited, specialists in cryochain technology for sensitive cellular therapies. Asymptote’s integrated suite of cryochain hardware, software and consumables are designed to maintain the potency of cellular therapies enabling ultra-low temperature freezing during production, all the way to thawing at the clinic prior to administering to patients. The acquisition of Asymptote fills a critical gap in GE Healthcare’s end-to-end ecosystem of products and services for cell therapy production, and will be an important piece of the portfolio enabling the industrialization of these life-saving therapies.

Cellular therapies are rapidly changing the healthcare landscape by providing life-saving and potentially curative treatments for many of the world’s most challenging diseases, especially cancer. The cell therapy oncology market alone is expected to reach $30 billion by 2030 with almost 800 potentially life-changing therapies in clinical trials at the end of 2016 (1).

Story Continues Below Advertisement

New & Refurbished C-Arm Systems. Call 702.384.0085 Today!

KenQuest provides all major brands of surgical c-arms (new and refurbished) and carries a large inventory for purchase or rent. With over 20 years in the medical equipment business we can help you fulfill your equipment needs

As the cell therapy market develops, demand for manufacturing and clinical delivery will increase. With this increase in demand, new Current Good Manufacturing Practices (cGMP) challenges emerge. The UK-based Asymptote makes pioneering technologies that challenge standard cell cryopreservation and thawing practices and support cGMP. The company’s innovative, digitally-enabled hardware products significantly lower the risk of contamination found in conventional processes and provide exceptional control and analytics of cryochain procedures.

Ger Brophy, General Manager of GE Healthcare’s Cell Therapy business said: “Asymptote’s high-quality offering takes us another step forward in our vision to industrialize cell therapy, and in providing reliable and high-quality services for our customers and patients around the world. We want to improve the access to cellular therapies and tap the great potential that they have in curing some of our most difficult diseases. Finding ambitious technologies and partners like Asymptote, we are one step closer to realizing that goal.”

John Morris, Founder and CEO, Asymptote Limited, said: “Asymptote is delighted to become part of GE Healthcare. Our vision, current portfolio and exciting pipeline of cryochain technology is a great fit with GE’s Cell Therapy division. Our innovative range of liquid nitrogen-free controlled rate freezers are already widely used in the cryopreservation of cellular based therapies. The acquisition gives us the opportunity to reach a larger audience through the local specialist GE Cell Therapy team, provides us with a strong platform for our product launches, and allows us to significantly scale up our product development.”
  Pages: 1 - 2 >>

Business Affairs Homepage

You Must Be Logged In To Post A Comment

Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Gold Service Dealer Program
Receive RFP/PS
Healthcare Providers
See all
HCP Tools
A Job
Parts Hunter +EasyPay
Get Parts
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to, Inc. Copyright ©2001-2018, Inc.